Literature DB >> 31396360

A medical mirroring: chronic myelomonocytic leukemia mimicking immunoglobulin G4-related disease.

Zhiqian Bai1, Yuxue Chen1, Xiaoqi Chen2, Lingli Dong1.   

Abstract

Chronic myelomonocytic leukemia (CMML) can be complicated by autoimmune features associated with rheumatologic disorders, which have been commonly reported by more researches currently. The intrinsic correlation between CMML and autoimmune diseases can create significant pitfalls in differential diagnosis. CMML occasionally presents with clinical and histopathological manifestations that are similar to those of Immunoglobulin G4-related disease (IgG4-RD), a newly recognized systemic autoimmune disorder. Both CMML and IgG4-RD can have significant overlaps due to the common nature of these systemic disorders, especially when atypical clinical phenotypes are present. It is significant for physicians to accurately distinguish CMML and IgG4-RD because the therapy modalities could differ extremely between the two entities. Here we present a unique case of a 70-year-old female who had a condition that mimicked the onset of IgG4-RD not only in terms of clinical manifestations but also in serology and histopathology analyses. Following a series of rigorous examinations, this patient was ultimately diagnosed as having CMML. Herein, we discuss the aspects of IgG4-RD's differential diagnosis and the need for careful comparison of clinical and laboratory features as well as consideration of the pathogenesis of both IgG4-RD and CMML. We also stress a concept that the presence of autoimmune conditions cannot be the sole basis to exclude diagnosis of CMML, as these disorders can appear concomitantly.

Entities:  

Keywords:  Chronic myelomonocytic leukemia (CCML); IgG4-related disease (IgG4-RD); autoimmune diseases (AIDs); malignancy

Year:  2019        PMID: 31396360      PMCID: PMC6684895     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  17 in total

1.  Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis.

Authors:  Tomohiro Watanabe; Kouhei Yamashita; Saori Fujikawa; Toshiharu Sakurai; Masatoshi Kudo; Masahiro Shiokawa; Yuzo Kodama; Kazushige Uchida; Kazuichi Okazaki; Tsutomu Chiba
Journal:  Arthritis Rheum       Date:  2012-03

Review 2.  Consensus statement on the pathology of IgG4-related disease.

Authors:  Vikram Deshpande; Yoh Zen; John Kc Chan; Eunhee E Yi; Yasuharu Sato; Tadashi Yoshino; Günter Klöppel; J Godfrey Heathcote; Arezou Khosroshahi; Judith A Ferry; Rob C Aalberse; Donald B Bloch; William R Brugge; Adrian C Bateman; Mollie N Carruthers; Suresh T Chari; Wah Cheuk; Lynn D Cornell; Carlos Fernandez-Del Castillo; David G Forcione; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Gregory Y Lauwers; Yasufumi Masaki; Yasuni Nakanuma; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant V Sahani; Thomas C Smyrk; James R Stone; Masayuki Takahira; George J Webster; Motohisa Yamamoto; Giuseppe Zamboni; Hisanori Umehara; John H Stone
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

Review 3.  IgG4-related disease.

Authors:  Terumi Kamisawa; Yoh Zen; Shiv Pillai; John H Stone
Journal:  Lancet       Date:  2014-12-04       Impact factor: 79.321

Review 4.  International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.

Authors:  A Khosroshahi; Z S Wallace; J L Crowe; T Akamizu; A Azumi; M N Carruthers; S T Chari; E Della-Torre; L Frulloni; H Goto; P A Hart; T Kamisawa; S Kawa; M Kawano; M H Kim; Y Kodama; K Kubota; M M Lerch; M Löhr; Y Masaki; S Matsui; T Mimori; S Nakamura; T Nakazawa; H Ohara; K Okazaki; J H Ryu; T Saeki; N Schleinitz; A Shimatsu; T Shimosegawa; H Takahashi; M Takahira; A Tanaka; M Topazian; H Umehara; G J Webster; T E Witzig; M Yamamoto; W Zhang; T Chiba; J H Stone
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

Review 5.  Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence?

Authors:  Thorsten Braun; Pierre Fenaux
Journal:  Best Pract Res Clin Haematol       Date:  2013-10-01       Impact factor: 3.020

6.  Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia.

Authors:  Dorothée Selimoglu-Buet; Orianne Wagner-Ballon; Véronique Saada; Valérie Bardet; Raphaël Itzykson; Laura Bencheikh; Margot Morabito; Elisabeth Met; Camille Debord; Emmanuel Benayoun; Anne-Marie Nloga; Pierre Fenaux; Thorsten Braun; Christophe Willekens; Bruno Quesnel; Lionel Adès; Michaela Fontenay; Philippe Rameau; Nathalie Droin; Serge Koscielny; Eric Solary
Journal:  Blood       Date:  2015-04-07       Impact factor: 22.113

Review 7.  Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.

Authors:  Kristen B McCullough; Mrinal M Patnaik
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

8.  A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution.

Authors:  Deniz Peker; Eric Padron; John M Bennett; Xiaohui Zhang; Pedro Horna; Pearlie K Epling-Burnette; Jeffrey E Lancet; Javier Pinilla-Ibarz; Lynn Moscinski; Alan F List; Rami S Komrokji; Ling Zhang
Journal:  Acta Haematol       Date:  2014-11-20       Impact factor: 2.195

Review 9.  Myelodysplastic syndromes and autoimmune diseases--case series and review of literature.

Authors:  Omar Al Ustwani; Laurie A Ford; Sheila J N Sait; Anne Marie W Block; Maurice Barcos; Carlos E Vigil; Elizabeth A Griffiths; James E Thompson; Eunice S Wang; Julian Ambrus; Meir Wetzler
Journal:  Leuk Res       Date:  2013-05-18       Impact factor: 3.156

Review 10.  Myelodysplastic syndromes: Contemporary review and how we treat.

Authors:  Naseema Gangat; Mrinal M Patnaik; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2016-01       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.